Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in Medication Overuse Headache Withdrawal
NCT00135122Phase 3Completed
- Sponsor
- Sørlandet sykehus
- Start
- Sep 2003
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in medication overuse headache (MOH) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Calculated Mean Headache (MH) at 6 days. Started Sep 2003; status: completed.
02
Drugs
prednisolone
03
Conditions
medication overuse headache (MOH)
Beyond the preview
Go deeper on NCT00135122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135122.